Ramtin Agah - 19 Jan 2024 Form 4 Insider Report for RenovoRx, Inc. (RNXT)

Role
Chief Medical Officer, Director
Signature
/s/ Ramtin, Agah
Issuer symbol
RNXT
Transactions as of
19 Jan 2024
Net transactions value
$0
Form type
4
Filing time
23 Jan 2024, 21:50:29 UTC
Previous filing
29 Mar 2023
Next filing
30 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RNXT Stock Option Award $0 +28,424 $0.000000 28,424 19 Jan 2024 Common Stock 28,424 $1.08 Direct F1
transaction RNXT Stock Option Award $0 +125,132 $0.000000 125,132 19 Jan 2024 Common Stock 125,132 $1.08 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 19, 2024, the Reporting Person was awarded a stock bonus of 28,424 shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan (the "Plan"). These shares were fully vested upon issuance to the Reporting Person, and expire on January 19, 2034.
F2 On January 19, 2024, the Reporting Person received a nonqualified stock option grant for 125,132 shares of common stock vesting over four years at a rate of 1/48 per month with no cliff, beginning vesting on February 1, 2024. The option will become fully vested and exercisable on February 1, 2028, and expires on January 19, 2034.